The global single-use filtration assemblies market size was exhibited at USD 3.19 billion in 2022 and is projected to hit around USD 17.73 billion by 2032, growing at a CAGR of 18.71% during the forecast period 2023 to 2032.
Key Pointers:
- North America accounted for the largest share of the market in 2022 with 36.47%.
- Asia Pacific market is projected to experience the highest growth rate of 21.76% in the market during the forecast period.
- The membrane filtration segment accounted for the largest share of over 47.18% in 2022.
- Depth filtration segment is expected to register the fastest CAGR of 19.16% from 2023 to 2030
- The bioprocessing/biopharmaceuticals market segment dominated the market in 2022, accounting for over 41.6% and also held the fastest revenue share.
- The filter segment dominated the market and held the largest revenue share of 21.9% in 2022
Single-use Filtration Assemblies Market Report Scope
The increasing demand for biopharmaceutical products, rising research and development activities, and the need for cost-effective filtration systems are the major drivers of the market. The biopharmaceutical industry is growing rapidly, with an increasing number of companies investing in R&D to bring new drugs and therapies to market. Biopharmaceutical products are sensitive to contaminants, which can affect their efficacy and safety.
Therefore, biopharmaceutical companies require high-quality filtration systems that can remove impurities and contaminants from their products. Single-use filtration assemblies offer several advantages over traditional filtration systems, such as reduced contamination risk, lower capital costs, and increased flexibility. As a result, the adoption of single-use filtration assemblies is increasing in the biopharmaceutical industry, which is expected to boost the industry growth during the forecast period.
The COVID-19 pandemic has had a major impact on the global market, particularly on the research and development of medical treatments for non-COVID-19 conditions, as well as the supply chain of biopharmaceuticals, pharmaceuticals, and medical devices. According to an article in the BioProcess International journal published in August 2021, 87% of respondents reported disruptions in the biopharma supply chains due to the pandemic. However, the market has begun to recover as research and development activities and pharmaceutical supply chains have resumed.
In addition, the COVID-19 pandemic had a significant impact on the market, as single-use technology was adopted for research activities in COVID-19 vaccine development. The rise in the production of COVID-19 treatment therapeutics, which in turn increased downstream processing that required separation and filtration and techniques. In August 2021, Brazilian and U.S. scientists published a research article where they evaluated the production process of COVID-19 adenoviral vector vaccines. They utilized TFF systems with a 300kDa membrane for recovery and concentration of the adenoviral vectors through two steps of ultrafiltration-diafiltration. These research studies, coupled with the mass manufacturing of COVID-19 vaccines and increasing investment for production expansion, are expected to drive the market's growth further.
Furthermore, the demand for effective biopharmaceutical drugs and products has increased due to the rising prevalence of chronic diseases among the population. This has resulted in an increased need for single-use assemblies, which is expected to drive market growth. For instance, in 2022, the FDA's Center for Drug Evaluation and Research approved 37 novel drugs as new molecular entities (NMEs) as new therapeutic biological products. The growing number of biological approvals is expected to increase the biopharmaceutical manufacturing process, leading to greater adoption of single-use assemblies during the forecast period.
Furthermore, increasing spending on life science research and development is also contributing to the development of new drugs.The International Federation of Pharmaceutical Manufacturers and Association (IFPMA) reported in 2022 that there has been a notable increase in drug development for certain disease areas. Specifically, there are currently 3,148 new drugs in development for cancer, 1,677 for immunology, and 1,668 for neurology. Additionally, the pharmaceutical sector in the UK has also seen a 6% increase in annual R&D spending, according to the Office for National Statistics (ONS) 2021 report, reaching a record high of Euro 5.02 billion (USD 5.34 billion). Hence, the increasing R&D spending is expected to lead to the development of more drugs and boost growth of the industry.
Single-use filtration assemblies are designed for one-time use and disposal, reducing their potential for reuse and leading to increased costs for some companies. However, the market growth of these assemblies is hindered primarily by high initial setup costs and biologics manufacturing, especially in developing and underdeveloped countries.
Some of the prominent players in the Single-use Filtration Assemblies Market include:
- Sartorius AG
- 3M Purification
- Danaher
- Repligen Corporation
- Merck Millipore
- Cellab
- Medela
- Thermo Fisher Scientific, Inc.
- MEISSNER FILTRATION PRODUCTS, INC.
- DrM, Dr. Mueller AG
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Single-use Filtration Assemblies market.
By Type
- Membrane Filtration
- Tangential Flow Filtration (TFF)
- Ultra/Diafiltration
- Micro-Filtration
- Direct Flow Filtration (DFF) /Dead-end Filtration /Normal Flow Filtration
- Depth Filtration
- Centrifugation
- Others
By Application
- Pharmaceuticals Manufacturing Market
- Bioprocessing/Biopharmaceuticals Market
- Laboratory Use
By Product
- Filters
- Cartridges
- Membranes
- Manifold
- Cassettes
- Syringes
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Request Customization
Get a Sample
Get a Sample
Request Customization